6.50% p.a. Early Redemption Kick-In GOAL

Underlying: Amgen / Gilead / Novartis / Roche SSPA/EUSIPA Product Type: Barrier Reverse Convertibles (1230, Auto-Callable) SIX symbol: KABATU / Valor: 35475443 / ISIN: CH0354754431

Last update 15.08.2018
  • Bid

    101.80 %
    Volume: 100'000

  • Ask

    102.80 %
    Volume: 100'000